Adam Kinnaird, MD, PhD, FRCSC

Adam Kinnaird, MD, PhD, FRCSC, discusses micro-ultrasound’s utility in active prostate cancer surveillance. In this 11-minute presentation, he outlines the evolution of prostate biopsy techniques and highlights micro-ultrasound’s ability to provide high-resolution imaging that detects prostate cancers invisible to conventional ultrasound. The Primus Scoring System, akin to the PI-RADS system for MRI, aids in classifying findings with promising accuracy in detecting clinically significant prostate cancer.

Dr. Kinnaird presents comparative studies showing micro-ultrasound as non-inferior to MRI in biopsy-naive patients. Preliminary data from trials reveal high concordance between micro-ultrasound and MRI. He highlights advancements in artificial intelligence, such as AI-driven heat maps for targeted biopsies, which show potential for improving diagnostic accuracy in both biopsy-naive and active surveillance settings.

The talk emphasizes the promise of micro-ultrasound in reducing overdiagnosis, improving patient outcomes, and potentially complementing or replacing MRI in specific clinical contexts.